H.-Y. Cheng

ORCID: 0000-0002-2400-4028
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Electron Spin Resonance Studies
  • Photochemistry and Electron Transfer Studies
  • Protein Interaction Studies and Fluorescence Analysis
  • Free Radicals and Antioxidants
  • Natural product bioactivities and synthesis
  • Bone Metabolism and Diseases
  • Metal complexes synthesis and properties
  • Nosocomial Infections in ICU
  • Antibiotic Resistance in Bacteria
  • Urinary Tract Infections Management
  • Pharmacological Effects of Natural Compounds

Shanxi Medical University
2023

Shaanxi Provincial People's Hospital
2023

GlaxoSmithKline (United States)
2003

South College
2003

New Frontier
1993

The Ohio State University
1982

Purpose: Cefoperazone/sulbactam is a β-lactam/β-lactamase inhibitor combination effective against intra-abdominal, urinary tract, and respiratory infections. Although some studies have suggested that cefoperazone/sulbactam associated with coagulation disorders, it remains debatable whether the of tigecycline or valproic acid increases risk bleeding, as both drugs can lead to disorders. This study aimed explore factors cefoperazone/sulbactam-induced coagulopathy. Patients Methods: was...

10.2147/idr.s429706 article EN cc-by-nc Infection and Drug Resistance 2023-09-01

Pharmacokinetic evaluation of the potent azepanone-based cathepsin K inhibitor 3 showed that it has an oral bioavailability 42% in rat and 4.8% monkey. The less than optimal bioavailabilities monkey precluded this analogue from being subjected to more detailed pharmacokinetic pharmacodynamic analyses. In vitro vivo studies aimed at identifying mechanisms which may be limiting these species served guide syntheses subsequent analogues for further evaluation. These have led identification...

10.1021/mp034017a article EN Molecular Pharmaceutics 2003-11-22
Coming Soon ...